$AMGN

AMGEN INC

CIK:0000318154|SEC Filings
v3.25.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands, shares in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues:      
Total revenues $ 36,751,000 $ 33,424,000 $ 28,190,000
Operating expenses:      
Cost of sales 12,037,000 12,858,000 8,451,000
Research and development 7,272,000 5,964,000 4,784,000
Selling, general and administrative 7,050,000 7,096,000 6,179,000
Other 1,312,000 248,000 879,000
Total operating expenses 27,671,000 26,166,000 20,293,000
Operating income 9,080,000 7,258,000 7,897,000
Other income (expense):      
Interest expense, net (2,755,000) (3,155,000) (2,875,000)
Other income, net 2,651,000 506,000 2,833,000
Total income before income taxes 8,976,000 4,609,000 7,855,000
Provision for income taxes 1,265,000 519,000 1,138,000
Net income $ 7,711,000 $ 4,090,000 $ 6,717,000
Earnings per share:      
Basic (in usd per share) $ 14.33 $ 7.62 $ 12.56
Diluted (in usd per share) $ 14.23 $ 7.56 $ 12.49
Weighted-average shares used in the calculation of earnings per share:      
Basic (in shares) 538 537 535
Diluted (in shares) 542 541 538
Product sales      
Revenues:      
Total revenues $ 35,148,000 $ 32,026,000 $ 26,910,000
Other revenues      
Revenues:      
Total revenues $ 1,603,000 $ 1,398,000 $ 1,280,000